BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38213730)

  • 1. Multi-omics identification of GPCR gene features in lung adenocarcinoma based on multiple machine learning combinations.
    Xie Y; Pan X; Wang Z; Ma H; Xu W; Huang H; Zhang J; Wang X; Lian C
    J Cancer; 2024; 15(3):776-795. PubMed ID: 38213730
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.
    Liu J; Shi Y; Zhang Y
    EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma.
    Shen K; Wang Q; Wang L; Yang Y; Ren M; Li Y; Gao Z; Zheng S; Ding Y; Ji J; Wei C; Zhang T; Zhu Y; Feng J; Qin F; Yang Y; Wei C; Gu J
    Eur J Med Res; 2023 Sep; 28(1):352. PubMed ID: 37716991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
    Shu J; Jiang J; Zhao G
    Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and Identification of Four Prognostic Genes Related to Immune Infiltration and G-Protein Coupled Receptors Pathway in Lung Adenocarcinoma.
    Wang Y; Qiu L; Chen Y; Zhang X; Yang P; Xu F
    Front Oncol; 2020; 10():622251. PubMed ID: 33628734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel ADCC-related gene signature for predicting the prognosis and therapy response in lung adenocarcinoma.
    Zhang L; Zhang X; Guan M; Zeng J; Yu F; Lai F
    Inflamm Res; 2024 May; 73(5):841-866. PubMed ID: 38507067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of T-cell exhaustion-related genes and prediction of their immunotherapeutic role in lung adenocarcinoma.
    Lian C; Li F; Xie Y; Zhang L; Chen H; Wang Z; Pan X; Wang X; Zhang J
    J Cancer; 2024; 15(8):2160-2178. PubMed ID: 38495503
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
    Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J
    Front Immunol; 2023; 14():1217590. PubMed ID: 37492563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational identification and experimental verification of a novel signature based on SARS-CoV-2-related genes for predicting prognosis, immune microenvironment and therapeutic strategies in lung adenocarcinoma patients.
    Wang Y; Xu Y; Deng Y; Yang L; Wang D; Yang Z; Zhang Y
    Front Immunol; 2024; 15():1366928. PubMed ID: 38601163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating multiple machine learning methods to construct glutamine metabolism-related signatures in lung adenocarcinoma.
    Zhang P; Pei S; Wu L; Xia Z; Wang Q; Huang X; Li Z; Xie J; Du M; Lin H
    Front Endocrinol (Lausanne); 2023; 14():1196372. PubMed ID: 37265698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the immunogenic cell death pathways in gastric adenocarcinoma: A multi-omics study.
    Gu R; Chen Z; Dong M; Li Z; Wang M; Liu H; Shen X; Huang Y; Feng J; Mei K
    Environ Toxicol; 2024 May; ():. PubMed ID: 38717048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma.
    Zhang Y; Wang Y; Chen J; Xia Y; Huang Y
    Front Immunol; 2023; 14():1183230. PubMed ID: 37671155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma.
    Zhang P; Pei S; Gong Z; Feng Y; Zhang X; Yang F; Wang W
    Front Immunol; 2023; 14():1115272. PubMed ID: 36776843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
    Chen M; Wang X; Wang W; Gui X; Li Z
    Front Immunol; 2022; 13():829057. PubMed ID: 35833114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing.
    Yang J; Liu K; Yang L; Ji J; Qin J; Deng H; Wang Z
    Front Immunol; 2023; 14():1174762. PubMed ID: 37287976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a novel prognostic model of inflammation-related gene signature of lung adenocarcinoma.
    Luo D; Feng W; Ma Y; Jiang Z
    Sci Rep; 2022 Aug; 12(1):14729. PubMed ID: 36042374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis and Reinforcement Learning of Hypoxic Genes Based on Four Machine Learning Algorithms for Estimating the Immune Landscape, Clinical Outcomes, and Therapeutic Implications in Patients With Lung Adenocarcinoma.
    Sun Z; Zeng Y; Yuan T; Chen X; Wang H; Ma X
    Front Immunol; 2022; 13():906889. PubMed ID: 35757722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma.
    Bao X; Shi R; Zhao T; Wang Y
    J Mol Med (Berl); 2020 Jun; 98(6):805-818. PubMed ID: 32333046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.